Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Retin Cases Brief Rep ; 16(2): 180-182, 2022 Mar 01.
Article in English | MEDLINE | ID: mdl-31425447

ABSTRACT

PURPOSE: The purpose of this report was to describe a case with paracentral acute middle maculopathy after oral intake of sumatriptan. METHODS: Case presentation. RESULTS: One patient showed typical findings on fundoscopic examination and optical coherence tomography consistent with paracentral acute middle maculopathy following oral intake of sumatriptan. CONCLUSION: Sumatriptan may be a trigger for paracentral acute middle maculopathy.


Subject(s)
Macular Degeneration , Retinal Diseases , Sumatriptan , Acute Disease , Administration, Oral , Humans , Macular Degeneration/chemically induced , Macular Degeneration/diagnostic imaging , Retinal Diseases/chemically induced , Retinal Diseases/diagnostic imaging , Sumatriptan/administration & dosage , Sumatriptan/adverse effects , Tomography, Optical Coherence
2.
Ocul Immunol Inflamm ; 28(1): 39-42, 2020.
Article in English | MEDLINE | ID: mdl-31415218

ABSTRACT

Purpose: The purpose of this report is to describe a case of bilateral Candida chorioretinitis complicated with choroidal neovascularization (CNV) and effectively treated with combined intravitreal bevacizumab and amphotericin B.Results: An 83-year-old patient was diagnosed with Candida chorioretinitis in both eyes. Optical coherence tomography and fluorescein angiography revealed CNV. Treatment using combined intravitreal bevacizumab and amphotericin B was initiated followed by a 4-weekly regimen of bevacizumab, eventually resulting in the regression of the subretinal fluid and intraretinal edema.Conclusion: Our study supports the combined use of intravitreal bevacizumab and amphotericin B in the management of CNV in Candida chorioretinitis.


Subject(s)
Amphotericin B/therapeutic use , Angiogenesis Inhibitors/therapeutic use , Antifungal Agents/therapeutic use , Candidiasis/drug therapy , Chorioretinitis/drug therapy , Choroidal Neovascularization/drug therapy , Eye Infections, Fungal/drug therapy , Aged, 80 and over , Bevacizumab/therapeutic use , Candidiasis/microbiology , Chorioretinitis/microbiology , Choroidal Neovascularization/diagnostic imaging , Choroidal Neovascularization/pathology , Coloring Agents/administration & dosage , Drug Therapy, Combination , Eye Infections, Fungal/microbiology , Fluorescein Angiography , Humans , Indocyanine Green/administration & dosage , Intravitreal Injections , Male , Subretinal Fluid , Tomography, Optical Coherence , Vascular Endothelial Growth Factor A/antagonists & inhibitors , Visual Acuity/physiology
3.
GMS Ophthalmol Cases ; 9: Doc34, 2019.
Article in English | MEDLINE | ID: mdl-31728261

ABSTRACT

We present a case of tubulointerstitial nephritis and uveitis (TINU) with nodular anterior scleritis and large-vessel arteritis. A 67-year-old patient was admitted to the hospital with high fever, thoracic pain, and weakness. Bilateral anterior uveitis was seen at that time. Laboratory examination showed acute renal failure. A renal biopsy was performed and showed pathognomonic signs of tubulointerstitial nephritis (TIN). Six months later, she developed ocular inflammation suggestive of nodular scleritis. One year after hospital admission, she presented with large-vessel arteritis. We describe a case of TINU with co-occurrence of scleritis and large-vessel arteritis.

SELECTION OF CITATIONS
SEARCH DETAIL
...